Neuralink targets $1 billion revenue by 2031, Bloomberg News reports
The company aims to operate five large clinics within six years and offer three versions of its brain device, including Telepathy for communication between the brain and machines, Blindsight for restoring vision, and Deep for treating tremors and Parkinson's disease, according to the report.
Neuralink did not immediately respond to a Reuters request for comment.
The company expects regulatory approval for its Telepathy device by 2029, with plans to perform 2,000 surgeries annually and generate $100 million in revenue, the report said. By 2030, Neuralink anticipates launching Blindsight, expanding surgeries to 10,000 per year and generating over $500 million in revenue.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
2 minutes ago
- Reuters
Roche to investigate whether new drug can delay or prevent Alzheimer's disease
July 27 (Reuters) - Swiss drugmaker Roche Holding (ROG.S), opens new tab plans to investigate whether an experimental medicine can delay or prevent Alzheimer's disease symptoms, it said on Sunday, as a part of the company's growing development programme for the disease. The clinical trial of the drug, Trontinemab, will target people who are at risk of cognitive decline and will aim to delay or prevent the symptoms of Alzheimer's, Roche said in a statement. Trontinemab is designed so that the drug is transported across the blood brain barrier—protective blood vessels that prevent chemicals in the bloodstream from entering the brain — in hopes of delivering more of the treatment to the brain. Rivals like Eli Lilly (LLY.N), opens new tab have been making progress in the complicated field of Alzheimer's recently, with Lilly's drug Kisunla getting a recommendation for approval for certain patients from the European Medicines Agency last week. Kisunla is already approved in the U.S. Treatments for Alzheimer's approved so far, including Eisai (4523.T), opens new tab and Biogen's (BIIB.O), opens new tab Leqembi and Lilly's Kisunla, are designed to clear sticky clumps of a protein called amyloid beta in the brain. They carry hefty price tags as well as the risk of serious brain swelling and bleeding.
The Independent
31 minutes ago
- The Independent
Boeing's fighter jet workers in the St. Louis area reject a contract offer
Boeing Co. expects more than 3,200 union workers at three St. Louis-area plants that produce U.S. fighter jets to strike after they rejected a proposed contract Sunday that included a 20% wage increase over four years. The International Machinists and Aerospace Workers union said the vote by District 837 members was overwhelmingly against the proposed contract. The existing contract was to expire at 11:59 p.m. Central time Sunday, but the union said a 'cooling off' period would keep a strike from beginning for another week, until Aug. 4. Union leaders had recommended approving the offer, calling it a 'landmark' agreement when it was announced last week. Organizers said then that the offer would improve medical, pension and overtime benefits in addition to pay. The vote came two days before Boeing planned to announce its second quarter earnings, after saying earlier this month that it had delivered 150 commercial airliners and 36 military aircraft and helicopters during the quarter, up from 130 and 26 during the first quarter. Its stock closed Friday at $233.06 a share, up $1.79. The union did not say specifically why members rejected the contract, only that it 'fell short of addressing the priorities and sacrifices' of the union's workers. Last fall, Boeing offered a general wage increase of 38% over four years to end a 53-day strike by 33,000 aircraft workers producing passenger aircraft. 'Our members are standing together to demand a contract that respects their work and ensures a secure future,' the union said in a statement. Dan Gillan, general manager and senior Boeing executive in St. Louis, said in a statement that the company is 'focused on preparing for a strike.' He described the proposal as 'the richest contract offer' ever presented to the St. Louis union. 'No talks are scheduled with the union,' said Gillan, who is also vice president for Boeing Air Dominance, the division for the production of several military jets, including the U.S. Navy's Super Hornet, as well as the Air Force 's Red Hawk training aircraft.
Reuters
32 minutes ago
- Reuters
US, Europe strike trade deal averting tariff threats
The United States has struck a framework trade deal with Europe, U.S. President Donald Trump announced on Sunday, averting a spiraling row between two allies who account for almost a third of global trade.
